Are you Dr. Vavinskaya?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
# MC8320
San Diego, CA 92103Phone+1 619-342-6817
Summary
- Dr. Vera (Krol) Vavinskaya, MD is a board certified pathologist in San Diego, California. She is currently licensed to practice medicine in California and Kentucky. She is affiliated with UC San Diego Medical Center - Hillcrest.
Education & Training
- University of Kentucky College of MedicineFellowship, Cytopathology, 2013 - 2014
- Indiana University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2014 - 2025
- KY State Medical License 2012 - 2015
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 1 citationsMulticenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03 - Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.Takuya Nakagawa, Jessica Santos, Chanond A Nasamran, Prakriti Sen, Sayed Sadat
International Journal of Cancer. 2024-04-15 - 4 citationsMultidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff
Journal of Cancer Research and Clinical Oncology. 2023-11-01